Diffusion changes due to hyperthermia treatment for locally advanced cervical cancer

Diffusion changes due to hyperthermia treatment for locally advanced cervical cancer - HT-diffusion-1

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44183

Enrollment

Registered

2017-12-12

Start date

2018-01-01

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with advanced cervical cancer who will receive MRI-guided hyperthermia as part of standard care. In addition, patients need to have a macroscopic tumour at the first hyperthermia treatment.

Exclusion criteria

Exclusion criteria: Claustrophobia

Design outcomes

Primary

Measure	Time frame
Diffusion changes in the tumour.	—

Secondary

Measure	Time frame
Perfusion changes in the tumour.	—

Countries

Netherlands

Outcome results